Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

RIYADH, Saudi Arabia–(BUSINESS WIRE/AETOSWire)– 500 Global, a multi-stage venture capital firm, and Sanabil Investments, a…

The move aims to position the emirate as a premier global entertainment and tourism hub while providing a new gateway for high-value travellers The post Ras Al Khaimah Airport unveils VVIP terminal: A new gateway for global luxury travel appeared first on Gulf Business.